Nick Buitrago-Pocasangre, MSc
Neuroimmunology Project ManagerDownloadHi-Res Photo
Cards
Contact Info
Hafler Lab
300 GEORGE ST
NEW HAVEN, Connecticut 06510
United States
Education
MSc
University of Hartford, Neuroscience (2020)
University of Hartford, Neuroscience (2020)
BS
UConn, Psychology (2016)
UConn, Psychology (2016)
About
Copy Link
Titles
Neuroimmunology Project Manager
Departments & Organizations
Education & Training
- MSc
- University of Hartford, Neuroscience (2020)
- BS
- UConn, Psychology (2016)
Research
Copy Link
Overview
Medical Research Interests
Autoimmune Diseases; Blood Cells; Brain; Central Nervous System; Immune System Diseases; Multiple Sclerosis; Nervous System Diseases; Neurosciences
ORCID
0000-0002-1333-4435- View Lab Website
Halfer Lab
Research at a Glance
Yale Co-Authors
Frequent collaborators of Nick Buitrago-Pocasangre's published research.
Research Interests
Research topics Nick Buitrago-Pocasangre is interested in exploring.
David A. Hafler, MD, FANA, MSc
Erin Longbrake, MD, PhD
Rong Fan, PhD
Giulia Biancon, PhD
Jennifer M. Kwan, MD, PhD
Lohith Gowda, MD, MRCP
Multiple Sclerosis
Publications
2025
Transcriptomic profiling after B-cell depletion reveals central and peripheral immune cell changes in multiple sclerosis
Wei J, Moon J, Yasumizu Y, Zhang L, Raddassi K, Buitrago-Pocasangre N, Deerhake M, Strauli N, Chen C, Herman A, Pedotti R, Raposo C, Yim I, Pappalardo J, Longbrake E, Sumida T, Axisa P, Hafler D. Transcriptomic profiling after B-cell depletion reveals central and peripheral immune cell changes in multiple sclerosis. Journal Of Clinical Investigation 2025, 135: e182790. PMID: 40067358, PMCID: PMC12126227, DOI: 10.1172/jci182790.Peer-Reviewed Original ResearchCitationsAltmetric
2024
Circulating tumor-reactive KIR+CD8+ T cells suppress anti-tumor immunity in patients with melanoma
Lu B, Lucca L, Lewis W, Wang J, Nogueira C, Heer S, Rayon-Estrada V, Axisa P, Reeves S, Buitrago-Pocasangre N, Pham G, Kojima M, Wei W, Aizenbud L, Bacchiocchi A, Zhang L, Walewski J, Chiang V, Olino K, Clune J, Halaban R, Kluger Y, Coyle A, Kisielow J, Obermair F, Kluger H, Hafler D. Circulating tumor-reactive KIR+CD8+ T cells suppress anti-tumor immunity in patients with melanoma. Nature Immunology 2024, 26: 82-91. PMID: 39609626, PMCID: PMC12285569, DOI: 10.1038/s41590-024-02023-4.Peer-Reviewed Original ResearchCitationsAltmetric
2023
Microfluidic Immuno‐Serolomic Assay Reveals Systems Level Association with COVID‐19 Pathology and Vaccine Protection (Small Methods 10/2023)
Kim D, Biancon G, Bai Z, VanOudenhove J, Liu Y, Kothari S, Gowda L, Kwan J, Buitrago‐Pocasangre N, Lele N, Asashima H, Racke M, Wilson J, Givens T, Tomayko M, Schulz W, Longbrake E, Hafler D, Halene S, Fan R. Microfluidic Immuno‐Serolomic Assay Reveals Systems Level Association with COVID‐19 Pathology and Vaccine Protection (Small Methods 10/2023). Small Methods 2023, 7 DOI: 10.1002/smtd.202370057.Peer-Reviewed Original ResearchPrior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination
Asashima H, Kim D, Wang K, Lele N, Buitrago-Pocasangre N, Lutz R, Cruz I, Raddassi K, Ruff W, Racke M, Wilson J, Givens T, Grifoni A, Weiskopf D, Sette A, Kleinstein S, Montgomery R, Shaw A, Li F, Fan R, Hafler D, Tomayko M, Longbrake E. Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination. JCI Insight 2023, 8: e168102. PMID: 37606046, PMCID: PMC10543713, DOI: 10.1172/jci.insight.168102.Peer-Reviewed Original ResearchCitationsAltmetricMicrofluidic Immuno‐Serolomic Assay Reveals Systems Level Association with COVID‐19 Pathology and Vaccine Protection
Kim D, Biancon G, Bai Z, VanOudenhove J, Liu Y, Kothari S, Gowda L, Kwan J, Buitrago‐Pocasangre N, Lele N, Asashima H, Racke M, Wilson J, Givens T, Tomayko M, Schulz W, Longbrake E, Hafler D, Halene S, Fan R. Microfluidic Immuno‐Serolomic Assay Reveals Systems Level Association with COVID‐19 Pathology and Vaccine Protection. Small Methods 2023, 7: e2300594-e2300594. PMID: 37312418, PMCID: PMC10592458, DOI: 10.1002/smtd.202300594.Peer-Reviewed Original ResearchCitationsAltmetricMicrofluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine Protection
Kim D, Biancon G, Bai Z, VanOudenhove J, Liu Y, Kothari S, Gowda L, Kwan JM, Buitrago-Pocasangre NC, Lele N, Asashima H, Racke MK, Wilson JE, Givens TS, Tomayko MM, Schulz WL, Longbrake EE, Hafler DA, Halene S, Fan R. Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine Protection. Small Methods. 2023 Oct;7(10):e2300594. doi: 10.1002/smtd.202300594. Epub 2023 Jun 13. PMID: 37312418; PMCID: PMC10592458.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Copy Link
Activities
activity Aligning Science Across Parkinson’s (ASAP)
03/06/2023 - PresentProfessional OrganizationsMember
Get In Touch
Copy Link
Contacts
Lab Number
Mailing Address
Hafler Lab
300 GEORGE ST
NEW HAVEN, Connecticut 06510
United States
Locations
300 George Street
Lab
Ste 353
New Haven, CT 06511
Social Media